Recurrent early pregnancy loss: Is miscarriage evaluation the missing link?

Contemporary Ob/Gyn

Volumn 53, Issue 10, 2008, Pages 50-55

  Stephenson, Mary D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 59149085151     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Edmonds DK, Lindsay KS, Miller JF, et al. Early embryonic mortality in women. Fertil Steril. 1982;38:447-453.
2. Wilcox AJ, Weinberg CR, O'Connor JF, al. Incidence of early loss of pregnancy. N Engl J Med. 1988;319:189-194.
3. Ohno M, Maeda T, Matsunobu A. A cytogenetic study of spontaneous abortions with direct analysis of chorionic villi. Obstet Gynecol. 1991;77:394-398.
4. Jacobs PA, Hassold T. Human Genetics. Berlin: Springer-Verlag; 1987:233-244.
5. Hassold T, Chiu D. Maternal age-specific rates of numerical chromosome abnormalities with special reference to trisomy. Hum Genet. 1985;70:11-17.
6. Simpson JL. Incidence and timing of pregnancy losses: relevance to evaluating safety of early prenatal diagnosis. Am J Med Genet. 1990;35:165-173.
7. Stephenson MD, Sierra S. Reproductive outcomes in recurrent pregnancy loss associated with a parental carrier of a structural chromosome rearrangement. Hum Reprod. 2006;21:1076-1082.
8. Stephenson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril. 1996;66:24-29.
9. Abalovich M, Gutierrez S, Alcaraz G, et al. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002;12:63-68.
10. Alexander EK, Marqusee E, Lawrence J, et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. 2004;351:241-249.
11. Hirahara F, Andoh N, Sawai K, et al. Hyper-prolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertill Steril. 1998;70:246-252.
12. Jordan J, Craig K, Clifton DK, et al. Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use. Fertll Steril. 1994;62:54-62.
13. Castelbaum AJ, Lessey BA. Infertility and implantation defects. Infertility and reproduction. Med Clin North Am. 2001;12:427-446.
14. Oates-Whitehead RM, Haas DM, Carrier JA. Progestogen for preventing miscarriage. Cochrane Database Syst Rev. 2003;4:CD003511.
15. Rey E, Kahn SR, David M, et al. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;361:901-908.
16. Kovalevsky G, Gracia CR, Berlin JA, et al. Evaluation of the association between hereditary thrombo-philias and recurrent pregnancy loss: a meta-analysis. Arch Intern Med. 2004;164:558-563.
17. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295-306.
18. Stephenson M, Kutteh W. Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol. 2007;50:132-145.
19. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996;174:1584-1589.
20. Rai R, Cohen H, Dave M, et al. Randomised controlled trial of aspirin and aspirin and heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ. 1997;314:253-257.